Effectiveness and safety of weekly therapy versus 3-weekly therapy of paclitaxel plus carboplatin in women with ovarian cancer: a protocol of systematic review and meta-analysis

INTRODUCTION: Network meta-analyses have confirmed that paclitaxel plus carboplatin could improve progression-free survival (PFS) and overall survival (OS) compared with platinum alone. However, detailed implementation schedule (weekly or 3-weekly therapy) was not specified in clinical practice guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Weitao, Fu, Yu, Dang, Yun, Cai, Bingxin, Tuo, Shumei, Mao, Baohong, Lin, Ru, Liu, Qing, Li, Yilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928320/
https://www.ncbi.nlm.nih.gov/pubmed/35296476
http://dx.doi.org/10.1136/bmjopen-2021-053182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928320/
https://www.ncbi.nlm.nih.gov/pubmed/35296476
http://dx.doi.org/10.1136/bmjopen-2021-053182

Ejemplares similares